Galderma Launches Alastin in Japan and Key Markets Across Asia Pacific

Galderma, a Swiss dermatology company listed on the SIX Swiss Exchange, announced the launch of its premium regenerative skincare brand Alastin across the JPAC region. The brand has recently launched in Taiwan, will soon launch in Japan, and has received approval for market entry in Singapore and South Korea, with planned introductions in September and November, respectively. This expansion is part of Galderma's strategy to strengthen its footprint in the Asia Pacific region, a key growth market for premium skincare. The company is a pure-play dermatology category leader, and this move targets the high-end consumer segment in these affluent markets.

Global Impact

Economically, this expansion taps into the fast-growing Asia Pacific luxury skincare market, projected to grow at 8-10% CAGR. Politically and socially, it reflects rising consumer demand for premium, science-backed skincare in key Asian economies.